Market Overview

Susan G. Komen®, Milburn Foundation and Inflammatory Breast Cancer (IBC) Research Foundation Raise More Than $635,000 in 31 Days to Take on Aggressive Breast Cancer

Share:

Susan G. Komen®, the Milburn Foundation, and the Inflammatory Breast
Cancer (IBC) Research Foundation have again shown their partnership to
be an impactful and powerful force against inflammatory breast cancer
(IBC) – an aggressive subtype of the disease that is hard to diagnose
and treat. Together, in just 31 days, the organizations raised more than
$635,000 for research aimed at finding innovative new approaches to
diagnosing and treating IBC and other Komen programs.

During the month of March, Milburn and IBC Research Foundation matched
all donations to Komen up to a predetermined amount with a goal to raise
$250,000 in funds specifically for research into IBC. This form of
breast cancer is particularly dangerous because it's hard to spot on a
mammogram, doesn't usually present with a lump, is easy to misdiagnose,
and spreads quickly. Further, about 30 percent of women diagnosed with
IBC will learn that their cancer has already spread, or metastasized, to
other parts of the body and is incurable.

"While we've made significant progress against breast cancer, more than
41,000 lives are lost each year in the U.S. to metastatic breast cancer,
and that's unacceptable," said Paula Schneider, President and CEO at
Susan G. Komen. "We'll reduce that number and save lives when we figure
out how to stop aggressive breast cancers like IBC. Through this
successful partnership with Milburn and IBC Research Foundation, we are
making an even greater impact together than we ever could alone."

The organizations are also setting milestones for the next three years
of continued partnership as they work to identify the most critical
questions in IBC and IBC research, and continue to seek out and fund
innovative IBC research.

"This partnership illustrates our continued leadership in funding
critical IBC research," said Bryon Davis, President of the Milburn
Foundation. "The impressive results of this campaign will help us reach
key milestones in support of this initiative. Together, we are curating
exceptional teams, defining a path forward and ensuring adequate
financial support that will have bold and positive implications in the
fight against IBC and support Susan G. Komen's Bold Goal."

"Patient advocacy is about taking an active role in defining the
critical conversations that will drive accelerated results," said Ginny
Mason, Executive Director of the IBC Research Foundation. "In our 19
years of work in IBC patient advocacy, this partnership with Susan G
Komen and Milburn is special given the way the team works together so
creatively to push key conversations forward. This year's campaign
success will result in benefits for the IBC community and more, as
critical research innovation is realized."

The partnership between the three organizations has now raised more than
$1.59 million to date, thanks to two earlier matching gift campaigns in
2016 and 2017. Funds raised have made it possible to invest in
breakthrough research, including studies in IBC, aggressive and
metastatic breast cancers, and is critical to achieving Komen's Bold
Goal to reduce U.S. breast cancer deaths by 50 percent by 2026.

About Susan G. Komen®

Susan G. Komen is the world's largest breast cancer organization,
funding more breast cancer research than any other nonprofit outside of
the federal government while providing real-time help to those facing
the disease. Komen has set a Bold Goal to reduce the current number of
breast cancer deaths by 50 percent in the U.S. by 2026. Since its
founding in 1982, Komen has funded more than $956 million in research
and provided more than $2.1 billion in funding to screening, education,
treatment and psychosocial support programs, serving millions of people
in 60 countries worldwide. Komen was founded by Nancy G. Brinker, who
promised her sister, Susan G. Komen, that she would end the disease that
claimed Suzy's life. That promise has become Komen's promise to all
people facing breast cancer. Visit komen.org
or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social.

About The Milburn Foundation

The Milburn Foundation is a private foundation that structures creative
strategic partnerships with both public charities and for profit
companies to drive philanthropic innovation for breast cancer research
and more. The Milburn Foundation was born out of a father's love for his
daughter when she was diagnosed with Triple Negative Inflammatory Breast
Cancer. Milburn is the proud recipient of the 2016 Susan G. Komen Reach
Award (for
fundraising innovation
). Organizations interested in inventive
Corporate Social Responsibility (CSR), Venture Philanthropy, Impact
Investing or Activist Philanthropy initiatives should contact us to
learn more about how our donations can be coupled with a strategic
partners' objectives to amplify impact. Find out more or contact us by
visiting TheMilburnFoundation.org.

About IBC Research Foundation

Since 1999 the Inflammatory Breast Cancer Research Foundation (IBCRF)
has been leading the way in improving the lives of those touched by
inflammatory breast cancer (IBC) through the power of action and
advocacy. This is accomplished by tenaciously fostering innovative
research, creatively educating stakeholders, and tirelessly advocating
for both current patients and IBC survivors.

As a web-based non-profit, IBCRF relies on its dedicated volunteers
across the country. Guided by the Medical Advisory Board, a group
of extraordinary oncology professionals, IBCRF has funded
patient-focused IBC research resulting in new discoveries as well
as clinical trials. Learn more at www.ibcresearch.org or
call 1-877-stop ibc. On social media? Join us on
Facebook
 and Twitter (@IBCResearch).

View Comments and Join the Discussion!